Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis (NCT06744855) | Clinical Trial Compass
TerminatedNot Applicable
Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis
Stopped: Not enough patients interested at the site
United States16 participantsStarted 2025-01-01
Plain-language summary
The goal of this study is to evaluate change in symptoms using semiconductor embedded gloves for hand osteoarthritis.
Who can participate
Age range
40 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
. Patients age 40-75
. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
. Patients who are willing and able to sign corresponding research subject consent form.
Exclusion criteria
. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in pain as measured by the Visual Analog Scale (VAS)
. Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
. Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
. Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
. Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
. Patient has a history of peripheral neuropathy
. Patient has chronic pain conditions unrelated to hand condition
. Patient has auto-immune or auto-inflammatory diseases